Home
/
MARIMED INC.
/
Financials
/
Quarterly
MARIMED INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MARIMED INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$33.21M
Nov 15, 2021
Q2
2021
Jun 30, 2021
$32.57M
Aug 16, 2021
Q1
2021
Mar 31, 2021
$24.64M
May 17, 2021
Q3
2021
Sep 30, 2020
$13.46M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$9.61M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$7.47M
May 17, 2021
Q3
2020
Sep 30, 2019
$11.22M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$25.67M
Aug 10, 2020
Q3
2019
Sep 30, 2018
$3.39M
Nov 29, 2019
Q2
2019
Jun 30, 2018
$2.94M
Aug 9, 2019
Q1
2018
Mar 31, 2018
$2.08M
May 15, 2018
Q3
2018
Sep 30, 2017
$1.72M
Nov 14, 2018
Q2
2018
Jun 30, 2017
$1.62M
Aug 14, 2018
Q1
2018
Mar 31, 2017
$1.15M
May 15, 2018
Q3
2017
Sep 30, 2016
$873.5K
Nov 14, 2017
Q2
2017
Jun 30, 2016
$647.4K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$614.5K
May 15, 2017
Q3
2016
Sep 30, 2015
$392.8K
Dec 22, 2016
Q2
2016
Jun 30, 2015
$54.5K
Dec 19, 2016
Q1
2016
Mar 31, 2015
$96.2K
Nov 1, 2016
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$40.76M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$39.61M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$37.96M
May 8, 2025
Q3
2025
Sep 30, 2024
$40.60M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$40.44M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$37.93M
May 8, 2025
Q3
2024
Sep 30, 2023
$38.80M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$36.52M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$34.38M
May 9, 2024
Q3
2023
Sep 30, 2022
$33.91M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$32.99M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$31.28M
May 9, 2023
Q3
2022
Sep 30, 2021
$33.21M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$32.57M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$24.64M
May 10, 2022
Q3
2020
Sep 30, 2020
$13.46M
Nov 9, 2020
Q2
2020
Jun 30, 2020
$9.61M
Aug 10, 2020
Q1
2021
Mar 31, 2020
$7.47M
May 17, 2021
Q3
2020
Sep 30, 2019
$4.21M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$3.66M
Aug 10, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.95M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($1.27M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($5.45M)
May 8, 2025
Q3
2025
Sep 30, 2024
($1.01M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($1.65M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($1.30M)
May 8, 2025
Q3
2024
Sep 30, 2023
($4.26M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($958.0K)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($645.0K)
May 9, 2024
Q3
2023
Sep 30, 2022
$2.71M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$1.82M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$4.19M
May 9, 2023
Q3
2022
Sep 30, 2021
$2.02M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$7.49M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$4.22M
May 10, 2022
Q3
2021
Sep 30, 2020
$1.66M
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.21M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($2.42M)
May 17, 2021
Q3
2020
Sep 30, 2019
($7.40M)
Nov 9, 2020
Q2
2020
Jun 30, 2019
$4.68M
Aug 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.60M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$1.14M
Aug 7, 2025
Q1
2025
Mar 31, 2025
($851.0K)
May 8, 2025
Q3
2025
Sep 30, 2024
$1.35M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$956.0K
Aug 7, 2025
Q1
2025
Mar 31, 2024
$2.02M
May 8, 2025
Q3
2024
Sep 30, 2023
$3.29M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$3.55M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$5.14M
May 9, 2024
Q3
2023
Sep 30, 2022
$5.74M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$4.50M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$7.05M
May 9, 2023
Q3
2022
Sep 30, 2021
$6.62M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$12.00M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$7.04M
May 10, 2022
Q3
2021
Sep 30, 2020
$3.40M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$2.10M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$1.01M
May 17, 2021
Q3
2020
Sep 30, 2019
$972.6K
Nov 9, 2020
Q2
2020
Jun 30, 2019
$5.35M
Aug 10, 2020